Download Mental Health Bulletin, July 2008

GI Cancers
May 2015
This bulletin covers aspects of esophageal, gastric, intestinal and colorectal cancers and should be
of interest to multidisciplinary teams working in this area.
Sections can include:
 Combined Modality Therapies
 Drug and Targeted Therapies
 Pathology, Staging, Polymorphisms & Biomarkers
 Prognosis, Survival & Risk Factors
 Radiotherapy & Imaging
 Supportive Care & Symptom Management
 Surgery
Many of the following articles are available online via the NHS Scotland Knowledge Network.
Please use the links where provided and your ATHENS password. A complete list of
available online journals and registration for ATHENS can be found at
www.knowledge.scot.nhs.uk/
If the article you require is not available via the NHS Scotland Knowledge Network and you
would like to request a print copy, please submit your request online at
www.quest.scot.nhs.uk
This bulletin contains a selection of material gathered from a search of the evidence base, and is
not intended to be comprehensive. Professional judgment should be exercised when appraising
the material. The Library takes no responsibility for the wording, content and accuracy of the
information supplied, which has been extracted in good faith from reputable sources. NHSGGC is
not responsible for the content of external internet sites.
Compiled by:
Kirsty Coltart
Subject Librarian
Beatson West of Scotland Cancer Centre
0141 301 7285, [email protected]
General
Abunassar M, Reinders J, Jonker DJ, et al. (2015). Review of anal cancer patients at the
Ottawa hospital. European Journal of Surgical Oncology 41,5:653-658.
Bauer K, Schroeder M, Porzsolt F, et al. (2015). Comparison of international guidelines on
the accompanying therapy for advanced gastric cancer: reasons for the differences.
Journal of Gastric Cancer 15,1:10-18.
Brannstrom F, Bjerregaard JK, Winbladh A, et al. (2015). Multidisciplinary team conferences
promote treatment according to guidelines in rectal cancer. Acta Oncologica 54,4:447-453.
Cools-Lartigue J, Spicer J and Ferri LE. (2015). Current status of management of malignant
disease: current management of esophageal cancer. Journal of Gastrointestinal Surgery
19,5:964-972.
Ghosn M, Kourie HR, Abdayem P, et al. (2015). Anal cancer treatment: current status and
future perspectives. World Journal of Gastroenterology 21,8:2294-2302.
Harlan LC, Eisenstein J, Russell MC, et al. (2015). Gastrointestinal stromal tumors:
Treatment patterns of a population-based sample. Journal of surgical oncology 111,6:702707.
Onyeuku NE, Ayala-Peacock DN, Russo SM, et al. (2015). The multidisciplinary approach to
the treatment of rectal cancer: 2015 update. Expert review of gastroenterology & hepatology
9,4:507-517.
Papamichael D, Audisio RA, Glimelius B, et al. (2015). Treatment of colorectal cancer in
older patients: International Society of Geriatric Oncology (SIOG) consensus
recommendations 2013. Annals of Oncology 26,3:463-476.
Shridhar R, Shibata D, Chan E, et al. (2015). Anal cancer: current standards in care and
recent changes in practice. CA: a Cancer Journal for Clinicians 65,2:139-162.
Stordeur S, Vlayen J, Vrijens F, et al. (2015). Quality indicators for oesophageal and gastric
cancer: a population-based study in Belgium, 2004-2008. European Journal of Cancer Care
24,3:376-386..
Combined Modality Therapies
Breugom AJ, van Gijn W, Muller EW, et al. (2015). Adjuvant chemotherapy for rectal cancer
patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a
Dutch Colorectal Cancer Group (DCCG) randomized phase III trial+. Annals of Oncology
26,4:696-701.
Cai G, Zhu J, Palmer JD, et al. (2015). CAPIRI-IMRT: a phase II study of concurrent
capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment
of recurrent rectal cancer. Radiation Oncology 10,1:57.
Dai T and Shah MA. (2015). Chemoradiation in oesophageal cancer. Best Practice &
Research in Clinical Gastroenterology 29,1:193-209.
Garcia M, Martinez-Villacampa M, Santos C, et al. (2015). Phase II study of preoperative
bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal
cancer. BMC Cancer 15,59.
2
GI Cancers, February 2015
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
Marinello FG, Frasson M, Baguena G, et al. (2015). Selective approach for upper rectal
cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom
necessary. Diseases of the Colon & Rectum 58,6:556-565.
Petrelli F, Coinu A, Lonati V, et al. (2015). A systematic review and meta-analysis of
adjuvant chemotherapy after neoadjuvant treatment and surgery for rectal cancer.
International journal of colorectal disease 30,4:447-457.
Pezzolo E, Modena Y, Corso B, et al. (2015). Germ line polymorphisms as predictive
markers for pre-surgical radiochemotherapy in locally advanced rectal cancer: a 5-year
literature update and critical review. European journal of clinical pharmacology 71,5:529-539.
Robb WB, Dahan L, Mornex F, et al. (2015). Impact of Neoadjuvant Chemoradiation on
Lymph Node Status in Esophageal Cancer: Post hoc Analysis of a Randomized
Controlled Trial. Annals of Surgery 261,5:902-908.
Salazar R, Capdevila J, Laquente B, et al. (2015). A randomized phase II study of
capecitabine-based chemoradiation with or without bevacizumab in resectable locally
advanced rectal cancer: clinical and biological features. BMC Cancer 15,60.
Drug & Targeted Therapies
Berger AK, Zschaebitz S, Komander C, et al. (2015). Palliative chemotherapy for
gastroesophageal cancer in old and very old patients: A retrospective cohort study at the
National Center for Tumor Diseases, Heidelberg. World Journal of Gastroenterology
21,16:4911-4918.
Berry SR, Cosby R, Asmis T, et al. (2015). Continuous versus intermittent chemotherapy
strategies in metastatic colorectal cancer: a systematic review and meta-analysis. Annals
of Oncology 26,3:477-485.
Di Bartolomeo M, Ciarlo A, Bertolini A, et al. (2015). Capecitabine, oxaliplatin and irinotecan
in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with
advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study.
European journal of cancer 51,4:473-481.
Garcia-Alfonso P, Chaves M, Munoz A, et al. (2015). Capecitabine and irinotecan with
bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study. BMC
Cancer 15,1:327.
Gruenberger T, Bridgewater J, Chau I, et al. (2015). Bevacizumab plus mFOLFOX-6 or
FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer:
the OLIVIA multinational randomised phase II trial. Annals of Oncology 26,4:702-708.
Kataoka K, Tsushima T, Mizusawa J, et al. (2015). A randomized controlled Phase III trial
comparing 2-weekly docetaxel combined with cisplatin plus fluorouracil (2-weekly DCF)
with cisplatin plus fluorouracil (CF) in patients with metastatic or recurrent esophageal
cancer: rationale, design and methods of Japan Clinical Oncology Group study
JCOG1314 (MIRACLE study). Japanese journal of clinical oncology 45,5:494-498.
Katayose Y, Yamamoto K, Nakagawal K, et al. (2015). Feasibility Assessment of Modified
FOLFOX-6 as adjuvant treatment after resection of liver metastases from colorectal
cancer: analyses of a multicenter phase II clinical trial (Miyagi-HBPCOG Trial-001).
Hepato-gastroenterology 62,138:303-308.
3
GI Cancers, February 2015
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
Koeberle D, Betticher DC, von Moos R, et al. (2015). Bevacizumab continuation versus no
continuation after first-line chemotherapy plus bevacizumab in patients with metastatic
colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06). Annals of
Oncology 26,4:709-714.
Masi G, Salvatore L, Boni L, et al. (2015). Continuation or reintroduction of bevacizumab
beyond progression to first-line therapy in metastatic colorectal cancer: final results of
the randomized BEBYP trial. Annals of Oncology 26,4:724-730.
Nishikawa K, Fujitani K, Inagaki H, et al. (2015). Randomised phase III trial of second-line
irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer
refractory to S-1 monotherapy: TRICS trial. European journal of cancer 51,7:808-816.
Petrelli F, Coinu A, Ghilardi M, et al. (2015). Efficacy of Oxaliplatin-based
Chemotherapy+Bevacizumab as First-line Treatment for Advanced Colorectal Cancer: A
Systematic Review and Pooled Analysis of Published Trials. American Journal of Clinical
Oncology 38,2:227-233.
Poulsen LO, Qvortrup C, Pfeiffer P, et al. (2015). Review on adjuvant chemotherapy for
rectal cancer - why do treatment guidelines differ so much?. Acta Oncologica 54,4:437446.
Ryu MH, Yoo C, Kim JG, et al. (2015). Multicenter phase II study of trastuzumab in
combination with capecitabine and oxaliplatin for advanced gastric cancer. European
journal of cancer 51,4:482-488.
Wade R, Duarte A, Simmonds M, et al. (2015). The Clinical and Cost Effectiveness of
Aflibercept in Combination with Irinotecan and Fluorouracil-Based Therapy (FOLFIRI) for
the Treatment of Metastatic Colorectal Cancer Which has Progressed Following Prior
Oxaliplatin-Based Chemotherapy: a Critique of the Evidence. PharmacoEconomics
33,5:457-466.
Xu HB, Huang F, Su R, et al. (2015). Capecitabine plus oxaliplatin (XELOX) compared with
5-fluorouracil/leucovorin plus oxaliplatin (FOLFOXs) in advanced gastric cancer: metaanalysis of randomized controlled trials. European journal of clinical pharmacology 71,5:589601.
Yaffee P, Osipov A, Tan C, et al. (2015). Review of systemic therapies for locally advanced
and metastatic rectal cancer. Journal of Gastrointestinal Oncology 6,2:185-200.
Yoshida M, Muro K, Tsuji A, et al. (2015). Combination chemotherapy with bevacizumab
and S-1 for elderly patients with metastatic colorectal cancer (BASIC trial). European
journal of cancer 51,8:935-941.
Pathology, Staging, Polymorphisms & Biomarkers
Dodou D and de Winter JC. (2015). Agreement between self-reported and registered
colorectal cancer screening: a meta-analysis. European Journal of Cancer Care 24,3:286298.
Healthcare Improvement Scotland. Bowel Screening Standards. March 2015
Kidney E, Berkman L, Macherianakis A, et al. (2015). Preliminary results of a feasibility
study of the use of information technology for identification of suspected colorectal
cancer in primary care: the CREDIBLE study. British journal of cancer 112,Suppl:S70-6.
4
GI Cancers, February 2015
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
Papadatos-Pastos D, Rabbie R, Ross P, et al. (2015). The role of the PI3K pathway in
colorectal cancer. Critical Reviews in Oncology-Hematology 94,1:18-30.
Pietrantonio F, Petrelli F, Coinu A, et al. (2015). Predictive role of BRAF mutations in
patients with advanced colorectal cancer receiving cetuximab and panitumumab: a metaanalysis. European journal of cancer 51,5:587-594.
Uppara M, Adaba F, Askari A, et al. (2015). A systematic review and meta-analysis of the
diagnostic accuracy of pyruvate kinase M2 isoenzymatic assay in diagnosing colorectal
cancer. World Journal of Surgical Oncology 13,1:48.
Webber EM, Kauffman TL, O'Connor E, et al. (2015). Systematic review of the predictive
effect of MSI status in colorectal cancer patients undergoing 5FU-based chemotherapy.
BMC Cancer 15,156.
Xu F, Xu L, Wang M, et al. (2015). The accuracy of circulating microRNA-21 in the
diagnosis of colorectal cancer: a systematic review and meta-analysis. Colorectal Disease
17,5:O100-7.
Prognosis, Survival & Risk Factors
Badgwell B, Roy-Chowdhuri S, Chiang YJ, et al. (2015). Long-term survival in patients with
metastatic gastric and gastroesophageal cancer treated with surgery. Journal of surgical
oncology 111,7:875-881.
Boyce M and Thomsen L. (2015). Gastric neuroendocrine tumors: prevalence in Europe,
USA, and Japan, and rationale for treatment with a gastrin/CCK2 receptor antagonist.
Scandinavian Journal of Gastroenterology 50,5:550-559.
Haller DG, O'Connell MJ, Cartwright TH, et al. (2015). Impact of age and medical comorbidity
on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of
individual patient data from four randomized, controlled trials. Annals of Oncology
26,4:715-724.
Hawkins NA, Berkowitz Z, Rodriguez J, et al. (2015). Examining Adherence With
Recommendations for Follow-Up in the Prevention Among Colorectal Cancer Survivors
Study. Oncology nursing forum 42,3:233-240.
Husson O, Mols F, Fransen MP, et al. (2015). Low subjective health literacy is associated
with adverse health behaviors and worse health-related quality of life among colorectal
cancer survivors: results from the profiles registry. Psycho-oncology 24,4:478-486.
Renfro LA, Grothey A, Kerr D, et al. (2015). Survival following early-stage colon cancer: an
ACCENT-based comparison of patients versus a matched international general
population+. Annals of Oncology 26,5:950-958.
van Gijn W, van Stiphout RG, van de Velde CJ, et al. (2015). Nomograms to predict survival
and the risk for developing local or distant recurrence in patients with rectal cancer
treated with optional short-term radiotherapy. Annals of Oncology 26,5:928-935.
Yang B, Jacobs EJ, Gapstur SM, et al. (2015). Active smoking and mortality among
colorectal cancer survivors: the cancer prevention study II nutrition cohort. Journal of
Clinical Oncology 33,8:885-893.
5
GI Cancers, February 2015
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
Radiotherapy & Imaging
Cai PQ, Lv XF, Tian L, et al. (2015). CT Characterization of Duodenal Gastrointestinal
Stromal Tumors. AJR.American Journal of Roentgenology 204,5:988-993.
Calais J, Dubray B, Nkhali L, et al. (2015). High FDG uptake areas on pre-radiotherapy
PET/CT identify preferential sites of local relapse after chemoradiotherapy for locally
advanced oesophageal cancer. European Journal of Nuclear Medicine & Molecular Imaging
42,6:858-867.
Freilich J, Hoffe SE, Almhanna K, et al. (2015). Comparative outcomes for three-dimensional
conformal versus intensity-modulated radiation therapy for esophageal cancer. Diseases
of the Esophagus 28,4:352-357.
Goon P, Morrison V, Fearnhead N, et al. (2015). High resolution anoscopy may be useful in
achieving reductions in anal cancer local disease failure rates. European Journal of Cancer
Care 24,3:411-416.
Mocellin S and Pasquali S. (2015). Diagnostic accuracy of endoscopic ultrasonography
(EUS) for the preoperative locoregional staging of primary gastric cancer. Cochrane
Database of Systematic Reviews 2,009944.
Supportive Care & Symptom Management
Bol N, Smets EM, Eddes EH, et al. (2015). Illustrations enhance older colorectal cancer
patients' website satisfaction and recall of online cancer information. European Journal of
Cancer Care 24,2:213-223.
Ma LN and Zhang RL. (2015). Risk, diagnosis and treatment to postoperative delirium in
elderly patients with gastrointestinal cancers. Hepato-gastroenterology 62,138:529-535.
McGregor LM, von Wagner C, Vart G, et al. (2015). The impact of supplementary narrativebased information on colorectal cancer screening beliefs and intention. BMC Cancer
15,162.
Mitchell G, Porter S and Manias E. (2015). A critical ethnography of communication
processes involving the management of oral chemotherapeutic agents by patients with a
primary diagnosis of colorectal cancer: study protocol. Journal of advanced nursing
71,4:922-932.
Otto SJ, Korfage IJ, Polinder S, et al. (2015). Association of change in physical activity and
body weight with quality of life and mortality in colorectal cancer: a systematic review
and meta-analysis. Supportive Care in Cancer 23,5:1237-1250.
Reis T, Khazzaka E, Welzel G, et al. (2015). Acute small-bowel toxicity during neoadjuvant
combined radiochemotherapy in locally advanced rectal cancer: determination of optimal
dose-volume cut-off value predicting grade 2-3 diarrhoea. Radiation Oncology 10,1:30.
Smith SG, Raine R, Obichere A, et al. (2015). The effect of a supplementary ('gist-based')
information leaflet on colorectal cancer knowledge and screening intention: a
randomized controlled trial. Journal of Behavioral Medicine 38,2:261-272.
Wong CK, Chen J, Yu CL, et al. (2015). Systematic review recommends the European
Organization for Research and Treatment of Cancer colorectal cancer-specific module for
measuring quality of life in colorectal cancer patients. Journal of clinical epidemiology
68,3:266-278.
6
GI Cancers, February 2015
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
Yoon SL, Grundmann O, Williams JJ, et al. (2015). Novel intervention with acupuncture for
anorexia and cachexia in patients with gastrointestinal tract cancers: a feasibility study.
Oncology nursing forum 42,2:E102-9.
Yoshida Y, Hoshino S, Aisu N, et al. (2015). Can grade 2 neutropenia predict the risk of
grade 3 neutropenia in metastatic colorectal cancer patients treated with chemotherapy?.
Supportive Care in Cancer 23,6:1623-1627.
Surgery
Andersen P, Andersen LM and Iversen LH. (2015). Iatrogenic ureteral injury in colorectal
cancer surgery: a nationwide study comparing laparoscopic and open approaches.
Surgical endoscopy 29,6:1406-1412.
Berho M, Narang R, Van Koughnett JA, et al. (2015). Modern multidisciplinary perioperative
management of rectal cancer. JAMA Surgery 150,3:260-266.
Bonjer HJ, Deijen CL, Abis GA, et al. (2015). A randomized trial of laparoscopic versus open
surgery for rectal cancer. New England Journal of Medicine 372,14:1324-1332.
Broholm M, Pommergaard HC and Gogenur I. (2015). Possible benefits of robot-assisted
rectal cancer surgery regarding urological and sexual dysfunction: a systematic review
and meta-analysis. Colorectal Disease 17,5:375-381.
Chen WK, Ren L, Wei Y, et al. (2015). General anesthesia combined with epidural
anesthesia ameliorates the effect of fast-track surgery by mitigating immunosuppression
and facilitating intestinal functional recovery in colon cancer patients. International journal
of colorectal disease 30,4:475-481.
Heneghan HM, Martin ST and Winter DC. (2015). Segmental vs extended colectomy in the
management of hereditary nonpolyposis colorectal cancer: a systematic review and
meta-analysis. Colorectal Disease 17,5:382-389.
Hu CY, Bailey CE, You YN, et al. (2015). Time trend analysis of primary tumor resection for
stage IV colorectal cancer: less surgery, improved survival. JAMA Surgery 150,3:245-251.
Kennedy E, Vella ET, Blair Macdonald D, et al. (2015). Optimisation of preoperative
assessment in patients diagnosed with rectal cancer. Clinical Oncology (Royal College of
Radiologists) 27,4:225-245.
Kobayashi S, Ito M, Yamamoto S, et al. (2015). Randomized clinical trial of skin closure by
subcuticular suture or skin stapling after elective colorectal cancer surgery. British
Journal of Surgery 102,5:495-500.
Lu C, Zhou S, Peng Z, et al. (2015). Quality of D2 lymphadenectomy for advanced gastric
cancer: is laparoscopic-assisted distal gastrectomy as effective as open distal
gastrectomy?. Surgical endoscopy 29,6:1537-1544.
Ma CC, Li P, Wang LH, et al. (2015). The value of single-incision laparoscopic surgery for
colorectal cancer: a systematic literature review. Hepato-gastroenterology 62,137:45-50.
Matsuda K, Hotta T, Takifuji K, et al. (2015). Randomized clinical trial of defaecatory
function after anterior resection for rectal cancer with high versus low ligation of the
inferior mesenteric artery. British Journal of Surgery 102,5:501-508.
Mobily M and Patel JA. (2015). Palliative percutaneous endoscopic gastrostomy placement
for gastrointestinal cancer: Roles, goals, and complications. World Journal of
Gastrointestinal Endoscopy 7,4:364-369.
7
GI Cancers, February 2015
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
Morino M, Risio M, Bach S, et al. (2015). Early rectal cancer: the European Association for
Endoscopic Surgery (EAES) clinical consensus conference. Surgical endoscopy 29,4:755773.
NICE. IPG514 Transanal total mesorectal excision of the rectum. March 2015
Shapiro M, Rashid NU, Whang EE, et al. (2015). Trends and predictors of resection of the
primary tumor for patients with stage IV colorectal cancer. Journal of surgical oncology
111,7:911-916.
Sun X, Yang C, Li K, et al. (2015). The impact of anesthetic techniques on survival for
patients with colorectal cancer: evidence based on six studies. Hepato-gastroenterology
62,138:299-302.
Sun ZC, Xu WG, Xiao XM, et al. (2015). Ultrasonic dissection versus conventional
electrocautery during gastrectomy for gastric cancer: A meta-analysis of randomized
controlled trials. European Journal of Surgical Oncology 41,4:527-533.
van der Schaaf M, Johar A, Wijnhoven B, et al. (2015). Extent of lymph node removal during
esophageal cancer surgery and survival. Journal of the National Cancer Institute 107,5:
Please note that the journal articles you are accessing are subject to the terms and conditions
imposed by the publisher, so there will be a limit on the number of articles an individual may
download or print from a single issue of a journal. You can consult your local NHSGGC library with
any queries.
If you have any questions regarding this or any other library services please contact Library staff –
contact details are at the beginning of the bulletin.
Sources used for this bulletin:
OVID MEDLINE, NICE, SIGN, Healthcare Improvement Scotland
8
GI Cancers, February 2015
Kirsty Coltart, Subject Librarian, NHSGGC Library Network